MidLantic Urology
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management (NCT05799248) | MidLantic Urology | 2023-04-27 |
Track MidLantic Urology automatically
Every clearance here is in the API, with alerts when new ones post.